The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations
AUTOR(ES)
Vaishnaw, Akshay K.
FONTE
American Society for Clinical Investigation
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=479708Documentos Relacionados
- The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations
- CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway
- Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.
- CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease.
- Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis.